pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: alvogen, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler alvogen, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

pyridostigmine bromide 180 mg/1

Manufacturer
Alvogen, Inc.

Identifiers & Regulatory

Product NDC 47781-335
Product ID 47781-335_0429e410-7623-2f45-6170-d4a2eadd8742
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204737
Listing Expiration 2026-12-31
Marketing Start 2015-06-29

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 47781335
Hyphenated Format 47781-335

Supplemental Identifiers

RxCUI
903847
UPC
0347781335304
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number ANDA204737 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30)
source: ndc

Packages (1)

47781-335-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30)

Ingredients (1)

pyridostigmine bromide (180 mg/1)

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0429e410-7623-2f45-6170-d4a2eadd8742", "openfda": {"upc": ["0347781335304"], "unii": ["KVI301NA53"], "rxcui": ["903847"], "spl_set_id": ["93454159-0c58-1980-34b9-4038a2260420"], "manufacturer_name": ["Alvogen, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30)", "package_ndc": "47781-335-30", "marketing_start_date": "20150629"}], "brand_name": "Pyridostigmine Bromide", "product_id": "47781-335_0429e410-7623-2f45-6170-d4a2eadd8742", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "47781-335", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Alvogen, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "180 mg/1"}], "application_number": "ANDA204737", "marketing_category": "ANDA", "marketing_start_date": "20150629", "listing_expiration_date": "20261231"}